GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Elizabeth Plimack discussing two abstracts: “Adjuvant nivolumab vs placebo for high-risk ...
Blood thinners prescribed after blood clots in the leg or lung initially increase the risk of bleeding, especially in women ...
The latest findings, published in the medical journal BMJ, show a "substantial" link between certain anticholinergic drugs ...
While blood clots serve an essential purpose in healing injuries, they can transform into life-threatening conditions when ...
KYZATREX is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX is safe or effective in males younger than 18 years old. Improper use may affect bone growth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback